Tag

Tag: Themis Bioscience

20/03/2020 3 mins

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

Themis Biosciences fundraising chikungunya vaccine

18/09/2019 2 mins

Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine

22/08/2019 2 mins

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

04/06/2019 2 mins

Austrian Biotech Raises €19M to Commercialize First Chikungunya Vaccine

06/05/2019 6 mins

2019 Will Be a “Year of Realism” for Biotech Investments

chikungunya virus mosquito Themis bioscience

06/11/2018 2 mins

First Potential Vaccine for Chikungunya Virus Flies Through Phase II

05/09/2017 2 mins

UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine

28/07/2017 1 min

More News! GSK’s Pipeline Shakeup, Bayer’s Failure & an EU Investigation

25/07/2017 6 mins

Trouble in Paradise: How Biotech is Fighting Tropical Diseases

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

Investors Must Be Ready for the Digitization of Biotech